Colorectal cancer screening in the geriatric population

Česká verzia

Authors: Nováková Karolína; Hálek Matěj; Falt Přemysl
Authors place of work: II. interní klinika – gastroenterologická a geriatrická FN Olomouc
Published in the journal: Geriatrie a Gerontologie 2022, 11, č. 4: 182-187
Category: Review Article

Summary

Colorectal cancer (CRC) is one of the most common malignant diseases in the world and Czech population. Screening programme for CRC was initiated in 2000. It has no upper age limit and it is entirely up to the referring physician to decide whether the screening is beneficial for the patient. Our paper presents updated data and evidence to support the decision on the indication of CRC screening in the geriatric population. The greatest benefit to the patient comes from early screening, with colonoscopy, which can detect endoscopically safely removable precancerous lesions. Careful consideration of the indication for screening is particularly relevant to the population over 75 years of age. The principal factors influencing the indication for screening colonoscopy are the risk of death from CRC, and the risks and benefits of screening itself. Cancer diagnosis alone does not benefit patients in terms of life expectancy; on the contrary, patients are at risk of complications from diagnostic and therapeutic colonoscopy. An individual approach to the completion of screening for each individual patient is in line with the emerging trend towards personalised medicine, but places far greater demands on the referring physician.

Keywords:

screening – colonoscopy – colorectal cancer – geriatric population – geriatry

Zdroje

1. Zavoral M, Suchánek S, Závada F, et al. Colorectal cancer screening in Europe. World Journal of Gastroenterology 2009; 15(47): 5907–5915.

2. Kolorektum.cz. 2022. Kolorektum. cz. [online] Dostupné na: https://www.kolorektum.cz/cs/ lekari/screeningovy-proces

3. Czech Society of Gastroenterology guidelines for diagnostic and therapeutic colonoscopy. Přemysl Falt, Ondřej Urban a spol., Gastroent Hepatol 2016; 70(6): 523–538.

4. US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 325(19): 1965–1977.

5. Helsingen LM, Vandvik PO, Jodal HC, et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline BMJ 2019; 367: 5515.

6. Paltiel O, Keidar Tirosh A, Paz Stostky O, et al. Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records. Journal of Medical Screening. 2021; 28(1): 25–33.

7. Sano Y, Byeon, JS, Li XB, et al. Colorectal cancer screening of the general population in East Asia. Digestive Endoscopy 2019; 28: 243–249.

8. Hongda Chen, Bin Lu, Min Dai. Colorectal Cancer Screening in China: Status, Challenges, and Prospects - China. China CDC Weekly 2022; 4(15): 322– 328.

9. Klervi Leuraud, Delphine Jezewski-Serra, Jérôme Viguier, et al. Colorectal cancer screening by guaiac faecal occult blood test in France: Evaluation of the programme two years after launching. Cancer Epidemiology 2013; 37: 6: 959–967.

10. Heisser T, Weigl K, Hoffmeister M, et al. Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluation. PLoS Med 2020; 17(7): e1003194.

11. Krzeczewski B, Hassan C, Krzeczewska O, et al. Cost-effectiveness of colonoscopy in an organized screening program. Pol Arch Intern Med 2021; 131: 128–135.

13. Colorectal cancer screening | HUS. Etusivu | HUS [online]. Copyright HUS 2022 [cit. 03.10.2022]. Dostupné z: https:// www.hus.fi/uen/patient/ treatments-and-examinations/ colorectal-cancer-screening

14. Holme Ø, Løberg M, Kalager M, et al. Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality: A Randomized Clinical Trial. JAMA 2014; 312(6): 606–615.

15. Gross CP, Soulos PR, Ross JS, et al. Assessing the impact of screening colonoscopy on mortality in the medicare population. J Gen Intern Med 2011; 26(12): 1441–9.

16. Walter LC, Covinsky KE. Cancer screening in elderly patients a framework for individualized decision making. JAMA 2001; 285(21): 2750–2756.

17. Fried LP, Kronmal RA, Newman AB, et al. Risk Factors for 5-Year Mortality in Older Adults: The Cardiovascular Health Study. JAMA 1998; 279(8): 585-592.

18. Zauber AG, Winawer SJ, O‘Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 23; 366(8): 687–96.

19. Day LW, Kwon A, Inadomi JM, et al. Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. Gastrointest Endosc 2011; 74(4): 885–96.